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Association of serum magnesium levels with risk factors, 
severity and prognosis in ischemic and hemorrhagic stroke 
patients 
 
Abstract 
Background: Stroke is the third leading cause of mortality worldwide. One of the factors 
that affect the occurrence of stroke can be attributed to changes in the levels of trace 
elements. Accumulating evidence has been shown that magnesium, as an important 
element, is a new predictor of stroke. We aimed to determine the levels of Mg in ischemic 
stroke patients in comparison with those having the hemorrhagic type. 
Methods: This study was conducted on 447 stroke patients. Demographic characteristics 
of patients, stroke severity, and risk factors such as hypertension, ischemic heart disease, 
diabetes mellitus, and hyperlipidemia were recorded. Stroke was diagnosed based on the 
neurological examination and neuroimaging findings e.g. computed tomography (CT) or 
magnetic resonance imaging (MRI). The colorimetric technique was used to determine the 
concentration of Mg at 450 nm according to the commercial kit. 
Results: The mean of magnesium levels in ischemic patients was significantly higher than 
that in the hemorrhagic patients (P=0.001). Difference in magnesium status was associated 
with gender in thrombotic patients (P<0.05), while hyperlipidemia was associated with the 
status of magnesium in embolic patients (P=0.012). Furthermore, magnesium levels were 
correlated with ischemic heart disease in embolic (P=0.011) and sub-arachnoid 
hemorrhagic (SAH) patients (P=0.012), and with diabetes mellitus in thrombotic patients 
(P=0.012). Magnesium status was associated with the severity of ischemic stroke at the 
time of discharge in ischemic patients (P<0.001). Mg levels had the best area under curve 
(AUC) for the discrimination of ischemic patients from hemorrhagic ones. 
Conclusion: Magnesium levels were higher in ischemic patients compared to hemorrhagic 
ones, and these levels were associated with many risk factors contributing to a stroke. 
Magnesium may be used as a new predictor of stroke in ischemic patients as opposed to 
hemorrhagic ones. 
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Stroke is the leading cause of disability and mortality worldwide. Over 80% of all 
strokes in the world happen in the developing countries and studies conducted on these 
regions indicate remarkably higher fatality rates (1, 2). This neurological disorder imposes 
so many financial burdens on families and countries that it has become one of the most 
important healthcare issues in the world (3). According to the studies conducted in Iran, 
the incidence of stroke is 45 patients per 100,000 individuals among different populations 
(4). The main risk factors contributing to a stroke in Iran, like other parts of the world, 
include HTN (54%), hypercholesterolemia (15%), smoking (12%), IHD and DM (5). 
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Studies have demonstrated that stroke is associated with 
alterations in the balance of some trace elements. Indeed, 
trace elements are essential for maintaining the metabolism 
of neurons and glia (6, 7). Mg is an important trace element 
within the vascular system, and accumulating evidence has 
demonstrated that Mg has a key role in the pathogenesis of 
stroke and restoration of brain cells (8, 9). For example, 
animal studies have shown that Mg has a protective role in 
the integrity of blood brain barrier (BBB) and reduces edema 
after stroke as well as increases the antioxidant capacity in 
the lesion area through stimulation of antioxidant enzymes 
(10). The protective role of Mg at different age categories is 
discussed in details by Ingram Lingam and Nicola H 
Robertson in the review (11). It has also been shown that 
subjects with stroke have abnormalities in their serum and 
CNS Mg levels (12). Some studies indicate that a low serum 
Mg level promotes the risk of ischemic stroke, partially 
through affecting type 2 diabetes, HTN, and metabolic 
syndrome (13, 14) although some have suggested that Mg is 
independently associated with cerebrovascular diseases (15, 
16). However, few, if any, studies have ever examined Mg 
status among ischemic and hemorrhagic stroke patients. 
Therefore, the purpose of this study was to investigate the 
serum level of Mg among ischemic and hemorrhagic stroke 
patients and its relationship with the risk factors of these 
subtypes of stroke such as HTN, IHD, DM, and HLP, as well 
as the severity of stroke at admission and discharge to find 
whether Mg status can be introduced as a novel predictor in 
these patients. 
 
 
Methods 
Study population: This cross-sectional analytic study was 
performed on 447 stroke patients recruited from Ayatollah-
Rouhani Hospital in Babol, Iran. This hospital is the main 
center for admission of stoke patients in Babol and the 
surrounding areas, and the patients of the present study were 
chosen from among those referring to the hospital from May 
2015 to May 2017. Written consent was obtained from all 
subjects. The study was approved by the Ethics Committee 
of the Babol University of Medical Sciences (3407-
9542120). Demographic characteristics of patients, type and 
severity of stroke, risk factors such as HTN, IHD, DM, HLP, 
and smoking were recorded in a checklist. The study 
population was divided into two main groups (ischemic 
stroke group and hemorrhagic stroke group), and each main 
group was further divided into two sub-groups, namely: 
embolic and thrombotic for the ischemic group, and 
intracerebral hemorrhagic (ICH) and sub-arachnoid 
hemorrhagic (SAH) for the hemorrhagic group. Stroke was 
diagnosed based on the neurological examination and 
neuroimaging findings. Computed tomography (CT) or 
magnetic resonance imaging (MRI) was performed for all 
patients. Although CT scans determine subarachnoid blood 
in patients with CT-negative, lumbar puncture (LP) was 
performed to determine subarachnoid blood(4). Diagnosis of 
stroke and its types was made according to the criteria 
followed in epidemiological studies of stroke (17). Definitive 
diagnosis of all stroke cases was confirmed by the 
neurologist responsible to do the project. 
Severity of stroke was determined on the basis of NIH 
Stroke Scale (NIHSS) criteria, (18) where score ≤ 8 mild , 9 
– 15 moderate and ≥ 16 severe stroke. HTN was defined as 
more than 140 mm-Hg for systolic blood pressure (SBP) or 
more than 90 mm-Hg for diastolic blood pressure (DBP). 
DM was defined as fasting blood sugar (FBS) more than 126 
mg/dL, HLP as deregulated lipid profile patients including 
low level of HDL, high level of LDL and high  triglyceride 
(19), and history of ischemic heart disease (IHD) was 
obtained from background information, history of cardiac 
medications, and ECG. Finally, patients were categorized as 
smokers if they had smoked at least 5 cigarettes per day in 
the last year. 
Exclusion criteria: Exclusion criteria for the patients were 
cases with hemiparesis or any focal neurological findings 
other than stroke including head trauma, metabolic 
encephalopathy, brain abscess, brain tumor, migraine 
attacks, and seizure (19). Transient ischemic attack (TIA) 
cases were also excluded from the study. Besides, patients 
with renal failure, liver disorders, and those taking 
corticosteroid drugs were excluded. 
Blood sampling and laboratory assessment: Serum 
samples were taken immediately after diagnosis of stroke 
and placed at -20˚C until use. Biochemical parameters 
including triglyceride (TG), FBS, and total cholesterol were 
measured using a commercially available kit. The serum Mg 
level was measured by Pars Azmoon kit (Pars Azmoon 
corporation, Iran, cat: 126500) according to the protocol. 
Magnesium was assessed based on xylidyl-blue which at 
alkaline ph Mg and xylidyl-blue produce a purple colored 
complex. The colorimetric technique was used to determine 
the concentration of Mg at 450 nm. The normal level of Mg 
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was considered between 1.5 and 2.3 g/dl, and the values less 
than 1.5 g/dl were considered as low level while values more 
than 2.3 g/dl were considered as high level(19). The serum 
Mg levels were measured along with other laboratory tests in 
the clinical laboratory of Ayatollah-Rouhani Hospital in 
Babol. 
Statistical analysis: In our study, the statistical data were 
analyzed quantitatively and qualitatively using SPSS 
(Version 24.0; SPSS Inc., Chicago, IL, USA). To determine 
the association of Mg serum levels with prognosis of stroke, 
we used chi-square test, and the relationship between other 
variables influencing the type of stroke and Mg serum status 
was examined by Fisher's Exact Test with calculation of 
odds ratio (OR) and 95% confidence interval (95% CI). 
Furthermore, p<0.05 were considered as significant. The 
diagnostic accuracies of Mg for the discrimination of 
ischemic stroke and hemorrhagic stroke patients were 
analyzed by receiver operating characteristic curves (ROC). 
The optimal cut-off values were selected based on the 
maximum value of sensitivity and specificity. 
 
 
Results 
Included in this cross-sectional study were 447 stroke 
patients of whom, 225(50.3%) were males and 222 (49.7%) 
were females. As with the type of stroke, 374 had the 
ischemic type, of whom 170 patients were embolic and the 
rest were thrombotic while of the 73 having the hemorrhagic 
type, 26 were SAH and 47 were ICH. With regard to the 
relationship between stroke types and risk factors, we 
observed that there was a significant difference between 
HTN and the types of stroke and their subgroups 
(thrombotic/embolic, ICH/SAH) (P=0.026, 0.043 and 0.003, 
respectively). In addition, 29 patients having ICH stroke and 
9 having SAH stroke had diabetes, while 18 having ICH as 
well as 17 having SAH did not have this disorder. Thus, 
according to this main risk factor, there was a significant 
difference between the subtypes of hemorrhagic stroke and 
DM (P=0.027). Moreover, considering the severity and 
status of stroke at discharge, we found a significant 
difference between the severity of stroke at the time of 
discharge in two types of stroke (P=0.034) and the subtypes 
of ischemic stroke (P=0.005). We also observed that 36.9% 
of the ischemic stroke patients and 76.7% of those having 
the hemorrhagic type had hypomagnesemia. Besides, the 
mean±SD serum levels of Mg in ischemic and hemorrhagic 
groups were 1.63±0.42 mg/dl, and 1.31±0.37 mg/dl 
respectively, and there was a significant difference between 
the two types of stroke with serum Mg status (P=0.001) 
while we did not find significant difference between serum 
Mg levels and both subtypes of ischemic as well as the 
hemorrhagic stroke (P=0.139, 0.426, respectively) (table 1). 
The results of our data demonstrated that the only 
significant difference in serum levels of Mg was between 
both genders of thrombotic stroke patients (P=0.049). 
According to our findings, there was a significant association 
between the subtypes of ischemic stroke (i.e., thrombotic and 
embolic) and HTN, so in the thrombotic patients having a 
history of HTN as opposed to thrombotic patients not having 
a history of HTN, serum levels of Mg was low, and these 
findings were also observed for embolic patients (both of 
them P<0.001).  
Moreover, there was a significant association of serum 
Mg levels with severity of ischemic stroke in comparison 
with hemorrhagic stroke at the time of discharge (P>0.05), 
and we also found that serum Mg levels were significantly 
associated with the severity of ischemic stroke at the time of 
discharge in thrombotic (P<0.001) and embolic patients 
(P=0.003), but they were not significantly associated with 
severity at the time of discharge in the hemorrhagic group 
(P>0.05).  
Meanwhile, we did not find a significant association 
between serum status of Mg with severity of stroke at the 
time of admission in ischemic and hemorrhagic groups plus 
their sub-groups (P>0.05 all of them). Besides, there were 
significant relationships between serum Mg levels with DM 
only in thrombotic groups (P=0.012). Finally, of the 447 
stroke cases, only in the subgroup of embolic, Mg serum 
status was associated with HLP (P=0.012) (table 2). We used 
logistic regression test to determine the effect of the 
measured variables on the risk of ischemic stroke. These 
findings demonstrated that serum Mg status is a risk factor 
for ischemic stroke and has a significant role (P=0.006, 
OR=5.43 and CI 95%= 1.61-18.31) (table 3). 
In addition, to estimate the diagnostic accuracy of Mg for 
the distinction of ischemic stroke patients from those having 
hemorrhagic stroke, ROC analysis was performed and the 
results were presented in figure 1.  According to the ROC 
analysis, the cutoff value of 1.35 mg/dl serum levels of Mg 
showed the best diagnostic accuracy for discriminating 
ischemic stroke patients from hemorrhagic ones: AUC=0.71, 
P< 0.001 and 95% CI = (0.634 – 0.758). 
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Table 1: Frequency of stroke patients according to gender, severity of stroke and distribution of risk factors, as well as the 
mean±standard deviation (SD) serum levels of Mg in type of stroke and subtype of ischemic (embolic and thrombotic) as 
well as hemorrhagic of stroke (ICH and SAH) 
  Ischemic of stroke Hemorrhagic of stroke 
Variable Subgroup Thrombotic  
%(N) 
Embolic 
%(N) 
P.value* ICH 
%(N) 
SAH 
%(N) 
P.value** 
Gender male 57.4(109) 42.6(81)  
0.261 
68.6(24) 31.4(11)  
0.473 female 51.6(95) 48.4(89) 60.5(23) 39.5(15) 
HTN Yes 60.5(98) 39.5(64)  
0.043 
78.6(33) 21.4(9) 0.003 
NO 50(106) 50(106) 45.2(14) 54.8(17) 
IHD Yes 50(81) 50(81) 0.123 64.9(24) 35.1(13) 0.931 
NO 58(123) 42(89) 63.9(23) 36.1(13) 
HLP Yes 56.5(14) 43.5(170) 0.45 62.1(18) 37.9(11) 0.737 
NO 52.6(100) 47.4(90) 65.9(29) 34.1(15) 
DM Yes 57.1(96) 42.9(72) 0.362 76.3(29) 23.7(9) 0.027 
NO 52.4(108) 47.6(98) 51.4(18) 48.6(17) 
Smoking  Yes 50.3(73) 49.7(72) 0.194 63.6(21) 36.4(12) 0.904 
NO 57.2(131) 42.8(98) 65.0(26) 35.0(14) 
 
Severity in admission time 
Mild 54.1(146) 45.9(124) 0.348 68.0(34) 32.0(16) 0.424 
Moderate 52.4(44) 47.6(40) 60.0(12) 40.0(8) 
Severe 70.0(14) 30.0(6) 33.3(1) 66.7(2) 
 
Severity in discharge time 
Mild 47.6(89) 52.4(98) 0.034 63.0(17) 37.0(10) 0.632 
Moderate 60.7(65) 39.3(42) 72.2(13) 27.8(5) 
Severe 58.6(34) 41.4(24) 68.8(11) 31.3(5) 
death 72.7(16) 27.3(6) 50.0(6) 50.0(6) 
 
Mg (mg/dl) 
Mean±SD Mean±SD  
0.139 
Mean±SD Mean±SD  
1.60±0.44 1.67±0.40 1.28±0.38 1.36±0.41 0.426 
         HTN: hypertension, IHD: ischemic heart disease, HLP: hyperlipidemia, DM: Diabetes Mellitus. 
         P.value *: indicating significant difference between thrombotic and embolic patients in ischemic of stroke.  
         P.value **: indicating significant difference between ICH and SAH patients in hemorrhagic of stroke. 
 
Table 2: Stroke types, risk factors and severity, considering of serum levels of Mg. 
Variable Serum levels of Mg (%) P.value 
Type of stroke  Low Normal 
 
Ischemic 
thrombotic Female 31.6(30) 68.4(65) 0.049* 
male 45.0(49) 55.0(60) 
Embolic Female 33.7(70) 66.3(59) 0.774 
male 35.8(29) 64.2(52) 
 
Hemorrhagic 
ICH Female 73.9(17) 26.1(6) 0.231 
male 80.9(38) 19.1(9) 
SAH Female 60.0(9) 40.0(6) 0.234 
male 81.8(9) 18.2(2) 
 HLP  
 
Ischemic 
thrombotic Negative 36.0(36) 64.0(64) 0.433 
positive 41.3(43) 58.7(61) 
Embolic negative 43.3(56.7) 56.7(51) 0.012* 
positive 25.0(20) 75.0(60) 
 
Hemorrhagic 
ICH negative 86.2(25) 13.8(4) 0.236 
positive 72.2(13) 27.8(5) 
SAH negative 66.7(10) 33.3(5) 0.741 
positive 72.7(8) 27.3(3) 
 HTN  
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Ischemic 
thrombotic Negative 25.5(27) 74.5(79) <0.001* 
positive 53.1(52) 46.9(49) 
Embolic negative 21.7(23) 78.3(83) <0.001* 
positive 56.3(36) 43.8(28) 
 
Hemorrhagic 
ICH negative 64.3(9) 35.7(5) 0.060 
positive 87.9(29) 12.1(4) 
SAH negative 70.6(12) 29.4(5) 0.837 
positive 66.7(6) 33.3(3) 
 Severity in discharge time  
 
 
 
 
Ischemic 
thrombotic Mild 24.7(22) 75.3(67) <0.001* 
Moderate 40.0(26) 60.0(39) 
Sever  73.5(25) 26.5(9) 
death 37.5(6) 62.5(10) 
Embolic Mild 24.5(24) 56.7(51) 0.003* 
Moderate 40.5(17) 75.0(60) 
Sever 58.3(14) 41.7(10) 
death 66.7(4) 33.3(2) 
 
 
 
 
Hemorrhagic 
ICH Mild 64.7(11) 35.5(6) 0.145 
Moderate 92.3(12) 7.7(1) 
Sever 81.8(9) 18.2(2) 
death 100.0(6) 0.0(0) 
SAH Mild 40.0(4) 60.0(6) 0.07 
Moderate 80.0(4) 20.0(1) 
Sever 100.0(5) 0.0(0) 
death 83.3(5) 16.7(1) 
 IHD  
 
 
Ischemic 
Thrombotic Negative 35.0(43) 65.0(80) 0.174 
positive 25.8(23) 55.6(45) 
Embolic negative 25.8(23) 74.2(66) 0.011* 
positive 44.4(36) 55.6(45) 
 
 
Hemorrhagic 
ICH negative 69.6(6) 30.4(7) 0.060 
positive 91.7(23) 8.3(2) 
SAH negative 46.2(6) 53.8(7) 0.012* 
positive 92.3(12) 7.7(1) 
 DM  
 
Ischemic 
Thrombotic Negative 30.6(33) 69.4(75) 0.012* 
positive 47.9(46) 52.1(50) 
Embolic negative 32.7(33) 67.3(66) 0.512 
positive 37.5(27) 62.5(45) 
 
Hemorrhagic 
ICH negative 83.8(15) 16.7(3) 0.733 
positive 79.3(23) 20.7(6) 
SAH negative 76.5(13) 23.5(4) 0.272 
positive 55.6(5) 44.4(4) 
 Severity in admission time  
 
 
Ischemic 
thrombotic Mild  34.2(50) 65.8(96) 0.094 
Moderate 47.4(21) 52.3(23) 
severe 26.6(8) 18.4(6) 
Embolic Mild 32.2(40) 67.7(84) 0.205 
Moderate 37.5(15) 62.5(5) 
severe 66.7(4) 33.3(2) 
 
 
Hemorrhagic 
ICH Mild 85.3(29) 14.7(5) 0.237 
Moderate 75.0(9) 25.0(3) 
severe 0(0) 100(1) 
SAH Mild 56.3(9) 14.7(5) 0.234 
Moderate 87.5(7) 12.5(1) 
severe 100(2) 0(0) 
Intracerebral hemorrhage (ICH), Subarachnoid hemorrhage (SAH), Hyperlipidemia (HLP), Hypertension(HTN), Ischemic heart 
disease(IHD), Diabetes mellitus (DM).      P.value*: indicating significant difference between groups (<0.05). 
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Table 3: The risk of ischemic stroke with adjusted variables by logistic regression test 
 
Variable                                  Odds Ratio (OR) Confidence interval 95% P.value 
Gender 0.85 0.28-2.36 0.79 
Mg 5.43 1.61-18.31 0.006 
Mild stroke severity at admission   1.00 - 0.43 
Moderate stroke severity at admission   0.98 0.35-2.69 0.96 
Severe stroke severity at admission   5.15 0.41-63.8 0.20 
Mild stroke severity at discharge  1.00 - 0.47 
Moderate stroke severity at discharge 0.58 0.16-2.16 0.42 
Severe stroke severity at discharge 1.56 0.52-4.67 0.43 
Death stroke severity at discharge 2.08 0.30-14.51 0.45 
HTN 0.82 0.29-2.36 0.71 
IHD 0.95 0.38-2.36 0.91 
DM 1.29 0.52-3.19 0.57 
HLP 0.59 0.22-1.56 0.29 
Smoking  2.60 0.86-7.86 0.09 
 
Discussion 
To the best of our knowledge, this is the first study to 
investigate the relationship between the serum levels of Mg  
and demographic features, risk factors, and severity among 
ischemic and hemorrhagic stroke patients. The results of our  
study demonstrated that there was a significant difference 
between the Mg serum level detected in the ischemic stroke 
group and that of the hemorrhagic stroke patients. In contrast 
to our study, Bayir et al. reported that mean Mg serum status 
did not have a significant difference in ischemic and 
hemorrhagic stroke patients in comparison with a healthy 
group (P=0.74), which seems to be due to the small sample 
size (20). Similarly, Koksaldi et al. indicated that in acute 
stroke patients, the Mg serum levels did not have any 
statistically significant difference with those of the healthy 
group, and there was only a significant correlation between 
serum and CSF Mg levels (21). Additionally, another study 
reported that the mean serum Mg level in 200 patients with 
acute ischemic stroke was 1.71±0.51mg/dl of whom 32% 
had hypomagnesemia(22), while the mean Mg serum level in 
our study was 1.58±0.43 mg/dl of whom 37% had low Mg. 
Furthermore, Karadas et al. found that serum Mg levels were 
significantly lower in 26 patients with acute hemorrhagic 
stroke compared with 29 healthy individuals(23). However, 
our data showed that the mean of Mg levels in ischemic 
patients were higher than that of the hemorrhagic ones. 
These discrepancies between the studies mentioned may be 
due to geography of the living place, lifestyles and diet  
 
 
differences, which can significantly affect the results. 
However, the difference between the mean of Mg levels in 
different types of stroke may have a physiopathologic basis, 
which may be considered for future studies.   
Besides, we did not find any significant difference in 
serum Mg status between the subgroups of ischemic stroke 
(i.e., thrombotic and embolic) and those of hemorrhagic 
stroke (i.e., ICH and SAH). Furthermore, in a meta-analysis 
study,  a modest but statistically significant inverse 
association between Mg intake and risk of stroke was 
observed. Daily intake increment of 100 mg Mg/d was 
associated with an 8% reduction in the risk of total stroke, 
and Mg intake was inversely associated with risk of ischemic 
stroke but not with ICH and SAH (14), which was consistent 
with our results. 
Our findings also showed that the differences in Mg 
levels were significantly associated with gender in 
thrombotic patients and that HLP was significantly 
associated with Mg serum status in embolic patients. In this 
line, Akarolo-Anthony et al. observed that among women 
with ischemic stroke, the median status of Mg was not 
different in comparison with healthy individuals. They 
showed that there was no significant association between 
plasma level of Mg and the risk of total ischemic stroke, and 
when adjusted for HbA1c, history of DM, history of HTN, 
coronary heart disease, total/HDL cholesterol did not alter 
the risk estimates (RR=1.34, P.trend= 0.19)(24). In addition, 
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Ohira et al. in a cohort study observed that status of serum 
Mg positively correlated with both LDL- and HDL-
cholesterol levels in ischemic stroke patients. Furthermore, 
higher serum Mg levels were associated with lower 
prevalence of HTN and DM at baseline, and baseline serum 
Mg was inversely correlated with blood pressure and the 
prevalence of HTN and DM(13). Recently, a study reported 
that acute ischemic stroke patients with lower Mg levels also 
differed in lipid profile (higher HDL-cholesterol levels, but 
lower TG levels, and LDL-cholesterol levels), and that a 
significant correlation between Mg status at admission and 
gender and risk factors such as cigarette smoking, history of 
HTN, DM, coronary heart disease(25). HTN and DM could 
be mediators between serum Mg and the incidence of 
different types of stroke. Besides, these associations have 
also been detected in other prospective studies (26-28). Thus, 
the results of our study were similar to the studies of Ohira et 
al. and Shoujiang You et al. 
Difference in Mg levels was significantly associated with 
HTN in both subgroups of ischemic stroke, but not with both 
subtypes of hemorrhagic stroke. However, according to the 
findings in DM patients, we observed that there was a 
significant association between the status of Mg and the 
presence or absence of DM only in thrombotic patients, as 
opposed to other subgroups of stroke. With respect to the 
results of a previous study that reported the Mg levels to be 
associated with DM and HTN in ischemic stroke patients(29, 
30), we illustrated that Mg levels had a significant 
association with HTN in both subgroups of ischemic stroke 
and it was correlated with DM only in one subgroup of 
ischemic stroke (i.e., thrombotic patients). Given this 
finding, hypomagnesemia should be taken into account 
considering the relationship between serum Mg levels and 
DM and HTN in ischemic stroke patients, and this could be a 
subject for future studies. 
Several studies have investigated the effect of baseline 
Mg on stroke outcome. The role of serum Mg levels in 
ischemic recovery, however, remains controversial and 
deserves further investigation(31, 32). Severity of stroke at 
discharge is an important prognostic factor, and we found in 
both subgroups of ischemic stroke that there was a 
significant association between Mg serum levels and severity 
at discharge, but not at admission. Currently, there are few 
studies conducted in this line of inquiry. However, Siegler et 
al. reported that there were no significant differences in 
severity of stroke between patients with low admission Mg 
relative to patients with normal-to-high serum Mg levels, 
and it was proposed that Mg groups at baseline were not 
predictive of poor functional outcome, death or discharge 
disposition(33). Therefore, future studies are needed to shed 
more light on the association between Mg and severity at 
admission and discharge times. If the relationship between 
hypomagnesemia and stroke severity is confirmed, the 
question arises whether hypomagnesemia leads to severe 
stroke or more severe stroke will lead to hypomagnesemia. 
A more recent study has found that the plasma status of 
Mg was negatively associated with the risk of cardiovascular 
outcomes including coronary heart disease and atrial 
fibrillation (34, 35). Additionally, it appeared that serum Mg 
level was inversely correlated with von Willebrand factor 
status, which in turn was positively associated with the 
incidence of ischemic stroke (36). Hence, our findings 
indicate that serum Mg levels had a significant association 
with IHD in embolic ischemic stroke and in SAH of 
hemorrhagic stroke, which is similar to the results of the 
mentioned studies. 
Considering the findings about the relationship between 
stroke types and its risk factors, we found that there was a 
significant difference between HTN with the type of stroke 
and its subgroups, and that DM as the main risk factor of 
stroke, had a significant difference with regard to the 
subtypes of hemorrhagic stroke. Moreover, there was a 
significant difference in the severity of stroke at discharge in 
terms of the two types of stroke and the subtypes of ischemic 
stroke. In this line, many studies have demonstrated that 
stroke and its subgroups are associated with some risk 
factors such as HTN, DM,  IHD, and HLP (24, 25, 33), while 
our data did not show a significant association between IHD 
and HLP with types of stroke and their subgroups. In this 
regard, Ahangar et al. reported that hypertension was 
significantly associated with hemorrhagic stroke, while 
dyslipidemia was more associated with ischemic stroke. 
Meanwhile, they found that stroke was more prevalent in 
females (2). However, in the present study, from the risk 
factors studied, the HTN similarly was significantly 
associated with various types of stroke, while HLP, gender, 
IHD and smoking did not have significant association with 
the different types of stroke.     
According to the ROC analysis, we determined the 
diagnostic accuracy of the measured Mg and extracted the 
related cut-points and data. Based on the results of the ROC 
curve analysis, the cutoff value of 1.35 mg/dl serum levels of 
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Mg showed the best diagnostic accuracy for discriminating 
ischemic stroke patients from hemorrhagic ones with the 
AUC value of=0.71 which makes Mg consider as a potential 
marker. Definitely evaluating the diagnostic accuracy of Mg 
in large and longitudinal studies can open a new window for 
possible more applications of these molecules in the clinic.  
However, further large scale studies are needed to verify our 
results, and there are still some potential limitations that 
merit considerations. For instance, our study did not have 
healthy individuals as a control group to compare patients 
with different types of stroke with healthy persons. 
Furthermore, the short follow-up time is another limitation. 
Despite these limitations, the relatively high number of 
studied patients in comparison with similar studies on this 
topic was one of the strengths of this study. 
The mean of Mg levels in ischemic patients was 
significantly higher than hemorrhagic type. Difference in Mg 
levels was associated with gender in thrombotic patients, and 
HLP was associated with serum status of Mg in embolic 
patients. Besides, serum Mg levels were correlated with IHD 
in embolic and SAH patients and DM only in thrombotic 
patients. Moreover, serum Mg status was associated with the 
severity of ischemic stroke at discharge in ischemic stroke 
patients. Mg levels had the best AUC, sensitivity and 
specificity for discrimination of ischemic patients from 
hemorrhagic ones. 
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